FDA

FDA Adds New Compounding Pharmacy Regulations
FDA Adds New Compounding Pharmacy RegulationsNew plans are designed around feedback and a desire to increase safety checks.
FDA Wants Changes to Homeopathy Products
FDA Wants Changes to Homeopathy ProductsThe FDA is proposing changes to how it handles potentially harmful homeopathy products.
Drug Safety Communication on Gadolinium Contrast Agents
Drug Safety Communication on Gadolinium Contrast AgentsThe FDA has issued new warnings about retention of gadolinium retention after use of contrast agents for MRIs.
Safety Communication: Biotin May Interfere with Lab Test Results
Safety Communication: Biotin May Interfere with Lab Test ResultsBiotin, AKA vitamin B7, appears to significantly throw off the results of certain lab tests.
Baxter Issues Recall of Nexterone Injection
Baxter Issues Recall of Nexterone InjectionThe affected lots could contain particulate matter.
FDA: Febuxostat Linked with Increased Risk of Cardiac Death
FDA: Febuxostat Linked with Increased Risk of Cardiac DeathCompared to allopurinol, febuxostat has an increased risk of heart-related deaths.
New Smart Tech Improves Diabetes Management
New Smart Tech Improves Diabetes ManagementA new frontier of tools for diabetes management is here.
Compounded Injectables RecalledUnited Pharmacy is recalling glutamine/arginine/carnitine injections.
Tisagenlecleucel (Kymriah) for Acute Lymphoblastic Leukemia
Tisagenlecleucel (Kymriah) for Acute Lymphoblastic LeukemiaA new era of treatment has arrived—here’s what you need to know.
Midazolam Injections Recalled for Wrong Contents
Midazolam Injections Recalled for Wrong ContentsMidazolam syringes in blister packages contained syringes of Zofran.